Unconjugated hyperbilirubinemia with increased urobilinogen is seen in –
**Question:** Unconjugated hyperbilirubinemia with increased urobilinogen is seen in -
A. Hepatitis
B. Cirrhosis
C. Neonatal jaundice
D. Pregnancy-induced hyperbilirubinemia
**Core Concept:**
In the context of medical examinations, unconjugated hyperbilirubinemia refers to an elevation of unconjugated bilirubin in the blood, which is a key indicator of impaired bilirubin clearance or increased bilirubin production. Unconjugated bilirubin is a product of heme degradation in the liver and is conjugated into less toxic compounds like urobilinogen before being excreted through the gastrointestinal tract. Urobilinogen is a marker of liver function and gastrointestinal health.
**Why the Correct Answer is Right:**
The correct answer is **D** - Pregnancy-induced hyperbilirubinemia. This condition occurs due to the increased bilirubin production during pregnancy, particularly in the third trimester, when there is a significant increase in fetal hemoglobin breakdown. The liver's clearance capacity is also reduced during pregnancy, leading to elevated bilirubin levels. The combination of increased production and reduced clearance results in unconjugated hyperbilirubinemia.
**Why Each Wrong Option is Incorrect:**
A) **Hepatitis** generally refers to inflammation or infection of the liver, which would typically cause conjugated hyperbilirubinemia due to impaired liver function and reduced conjugation of bilirubin.
B) **Cirrhosis** is a chronic liver disease characterized by scarring, which impairs liver function. In cirrhosis, bilirubin levels are typically elevated due to reduced conjugation but not necessarily increased production.
C) **Neonatal jaundice** is a common condition in newborn infants, characterized by high bilirubin levels. However, it is usually conjugated hyperbilirubinemia due to immature liver function, rather than unconjugated hyperbilirubinemia like in pregnancy-induced hyperbilirubinemia.
**Clinical Pearl:**
Understanding the distinction between conjugated and unconjugated hyperbilirubinemia is essential in diagnosing and managing patients with jaundice. In cases of neonatal jaundice, we should focus on conjugated hyperbilirubinemia due to immature liver function. Pregnancy-induced hyperbilirubinemia, however, is primarily caused by increased unconjugated bilirubin. This distinction is crucial in guiding treatment decisions, particularly in cases where phototherapy is employed to reduce bilirubin levels in neonates.